关于 "Ligand for E3 Ligase" 的结果28+ 个结果
- Pomalidomide-PEG1-C2-N3CAS: 2271036-44-1
Pomalidomide-PEG1-C2-N3是一种合成的E3连接酶配体-linker偶联物,包含基于Pomalidomide的cereblon配体和1个单元PEG的linker。Pomalidomide-PEG1-C2-N3可通过PROTAC技术合成选择性的CDK6降解剂CP-10。CP-10诱导CDK6降解,DC50为2.1nM。
- (S,R,S)-AHPC-PEG5-COOHCAS: 2172820-14-1
(S,R,S)-AHPC-PEG5-COOH (VH032-PEG5-COOH) 是一种合成的 E3 连接酶配体-linker 偶联物,包含基于 (S,R,S)-AHPC 的 VHL 配体和 5 个单元 PEG linker。
- VH 032 amide-alkylC3-acidCAS: 2172819-73-5
Functionalized von-Hippel-Lindau protein ligand (VHL) for research and development; incorporates an E3 ligase ligand plus alkylC3 linker with terminal carboxylic acid ready for conjugation to a target protein ligand
- Thrombin Receptor Activator for Peptide 5 (TRAP-5)CAS: 141685-53-2
凝血酶受体激活剂 5 (TRAP-5) 也称为凝血因子 II 受体 (1-5) 或蛋白酶激活受体 1 (1-5),用于研究冠心病 (CHD)。
- Thalidomide-NH-CBP/p300 ligand 2CAS: 2484739-21-9
Thalidomide-NH-CBP/p300 ligand 2 (P-007) 是 CBP 和 p300 的 PROTAC 降解剂。
- Pomalidomide 4'-alkylC3-acidCAS: 2225940-47-4
Functionalized cereblon ligand for research and development; incorporates an E3 ligase ligand plus an alkylC3 linker with terminal acid ready for conjugation to a target protein ligand
- PD-1/PD-L1 Inhibitor 3 (trifluoroacetate salt)
A PD-1/PD-L1 interaction inhibitor
- Lenalidomide 4'-PEG1-amineCAS: 2624336-86-1
Functionalized cereblon ligand for PROTAC® research and development; incorporates an E3 ligase ligand plus a PEG1 linker with terminal amine ready for conjugation to a target protein ligand
- Pomalidomide 4'-alkylC4-acidCAS: 2225940-48-5
Functionalized cereblon ligand for PROTAC(R) research and development; incorporates an E3 ligase ligand plus an alkylC4 linker with terminal acid ready for conjugation to a target protein ligand
- Lenalidomide 4'-PEG2-amineCAS: 2624336-88-3
Functionalized cereblon ligand for PROTAC® research and development; incorporates an E3 ligase ligand plus a PEG2 linker with terminal amine ready for conjugation to a target protein ligand
- Pomalidomide 4'-alkylC6-acidCAS: 2225940-50-9
Functionalized cereblon ligand for PROTAC(R) research and development; incorporates an E3 ligase ligand plus an alkylC6 linker with terminal acid ready for conjugation to a target protein ligand
- Lenalidomide 4'-PEG3-amineCAS: 2624336-87-2
Functionalized cereblon ligand for PROTAC® research and development; incorporates an E3 ligase ligand plus a PEG3 linker with terminal amine ready for conjugation to a target protein ligand
- Pomalidomide 4'-alkylC8-acidCAS: 2305936-70-1
Functionalized cereblon ligand for PROTAC(R) research and development; incorporates an E3 ligase ligand plus an alkylC8 linker with terminal acid ready for conjugation to a target protein ligand
- VH 032 amide-PEG4-amineCAS: 2446474-04-8
Functionalized von-Hippel-Lindau protein ligand (VHL) for PROTAC® research and development; incorporates an E3 ligase ligand plus a PEG linker ready for conjugation to a target protein ligand
- Thalidomide 4'-oxyacetamide-alkylC1-PEG3-alkylC3-amineCAS: 2564466-93-7
Functionalized cereblon ligand for PROTAC® research and development; incorporates an E3 ligase ligand plus an alkylC1-PEG3-alkylC3 linker with terminal amine ready for conjugation to a target protein ligand
- VH 032 amide-alkylC2-acidCAS: 2172819-72-4
Functionalized von-Hippel-Lindau protein ligand (VHL) for PROTAC® research and development; incorporates an E3 ligase ligand plus alkylC2 linker with terminal carboxylic acid ready for conjugation to a target protein ligand
- VH 101 phenol-alkylC4-amineCAS: 2564467-03-2
Functionalized von-Hippel-Lindau protein ligand (VHL) for PROTAC® research and development; incorporates an E3 ligase ligand plus an alkylC4 linker with terminal amine ready for conjugation to a target protein ligand
- VH 032 amide-alkylC6-acidCAS: 2172819-75-7
Functionalized von-Hippel-Lindau protein ligand (VHL) for PROTAC® research and development; incorporates an E3 ligase ligand plus alkylC6 linker with terminal carboxylic acid ready for conjugation to a target protein ligand
| 货号 | 产品名称 | CAS号 | 靶点 / 通路 | 引用 | 结构 |
|---|---|---|---|---|---|
| GC61200 | Pomalidomide-PEG1-C2-N3 | 2271036-44-1 | PROTAC | ||
Pomalidomide-PEG1-C2-N3是一种合成的E3连接酶配体-linker偶联物,包含基于Pomalidomide的cereblon配体和1个单元PEG的linker。Pomalidomide-PEG1-C2-N3可通过PROTAC技术合成选择性的CDK6降解剂CP-10。CP-10诱导CDK6降解,DC50为2.1nM。 | |||||
| GC60009 | (S,R,S)-AHPC-PEG5-COOH | 2172820-14-1 | PROTAC | ||
(S,R,S)-AHPC-PEG5-COOH (VH032-PEG5-COOH) 是一种合成的 E3 连接酶配体-linker 偶联物,包含基于 (S,R,S)-AHPC 的 VHL 配体和 5 个单元 PEG linker。 | |||||
| GC59051 | THPTA ligand | 760952-88-3 | Signaling Pathways | ||
三(3-羟丙基三唑甲基)胺(THPTA) ligand是一种水溶性配体。 | |||||
| GC50718 | VH 032 amide-alkylC3-acid | 2172819-73-5 | PROTAC | ||
Functionalized von-Hippel-Lindau protein ligand (VHL) for research and development; incorporates an E3 ligase ligand plus alkylC3 linker with terminal carboxylic acid ready for conjugation to a target protein ligand | |||||
| GC73529 | FAP Ligand 1 | 2230625-76-8 | Others | ||
FAP Ligand 1(FL)是一种高亲和力FAP小分子配体,用于将附着的药物靶向表达FAP的成纤维细胞,可用于靶向癌症的放射成像研究。 | |||||
| GC71382 | RNF114 ligand 1 | 900137-36-2 | Others | ||
RNF114 ligand 1是E3泛素连接酶粘合剂。 | |||||
| GC71404 | hRIO2 kinase ligand-1 | 923841-73-0 | Others | ||
hRIO2 kinase ligand-1(com 9)是hRIO2激酶的配体,Kd值为520 nM。 | |||||
| GP10085 | Thrombin Receptor Activator for Peptide 5 (TRAP-5) | 141685-53-2 | Peptides | ||
凝血酶受体激活剂 5 (TRAP-5) 也称为凝血因子 II 受体 (1-5) 或蛋白酶激活受体 1 (1-5),用于研究冠心病 (CHD)。 | |||||
| GC45063 | Toll-Like Receptor 7 Ligand II | 226907-52-4 | Hepatitis | ||
A TLR7 agonist | |||||
| GC63543 | Thalidomide-NH-CBP/p300 ligand 2 | 2484739-21-9 | PROTAC | ||
Thalidomide-NH-CBP/p300 ligand 2 (P-007) 是 CBP 和 p300 的 PROTAC 降解剂。 | |||||
| GC12347 | Sulforhodamine 101 | 60311-02-6 | Fluorescence | ||
A red fluorescent dye | |||||
| GC50665 | Pomalidomide 4'-alkylC3-acid | 2225940-47-4 | PROTAC | ||
Functionalized cereblon ligand for research and development; incorporates an E3 ligase ligand plus an alkylC3 linker with terminal acid ready for conjugation to a target protein ligand | |||||
| GC52425 | PD-1/PD-L1 Inhibitor 3 (trifluoroacetate salt) | - | Immunology/Inflammation | ||
A PD-1/PD-L1 interaction inhibitor | |||||
| GC50669 | Lenalidomide 4'-PEG1-amine | 2624336-86-1 | PROTAC | ||
Functionalized cereblon ligand for PROTAC® research and development; incorporates an E3 ligase ligand plus a PEG1 linker with terminal amine ready for conjugation to a target protein ligand | |||||
| GC50674 | Pomalidomide 4'-alkylC4-acid | 2225940-48-5 | PROTAC | ||
Functionalized cereblon ligand for PROTAC(R) research and development; incorporates an E3 ligase ligand plus an alkylC4 linker with terminal acid ready for conjugation to a target protein ligand | |||||
| GC50684 | Lenalidomide 4'-PEG2-amine | 2624336-88-3 | PROTAC | ||
Functionalized cereblon ligand for PROTAC® research and development; incorporates an E3 ligase ligand plus a PEG2 linker with terminal amine ready for conjugation to a target protein ligand | |||||
| GC50689 | Pomalidomide 4'-alkylC6-acid | 2225940-50-9 | PROTAC | ||
Functionalized cereblon ligand for PROTAC(R) research and development; incorporates an E3 ligase ligand plus an alkylC6 linker with terminal acid ready for conjugation to a target protein ligand | |||||
| GC50694 | Lenalidomide 4'-PEG3-amine | 2624336-87-2 | PROTAC | ||
Functionalized cereblon ligand for PROTAC® research and development; incorporates an E3 ligase ligand plus a PEG3 linker with terminal amine ready for conjugation to a target protein ligand | |||||
| GC50696 | Pomalidomide 4'-alkylC8-acid | 2305936-70-1 | PROTAC | ||
Functionalized cereblon ligand for PROTAC(R) research and development; incorporates an E3 ligase ligand plus an alkylC8 linker with terminal acid ready for conjugation to a target protein ligand | |||||
| GC50731 | VH 032 amide-PEG4-amine | 2446474-04-8 | PROTAC | ||
Functionalized von-Hippel-Lindau protein ligand (VHL) for PROTAC® research and development; incorporates an E3 ligase ligand plus a PEG linker ready for conjugation to a target protein ligand | |||||
| GC50709 | Thalidomide 4'-oxyacetamide-alkylC1-PEG3-alkylC3-amine | 2564466-93-7 | PROTAC | ||
Functionalized cereblon ligand for PROTAC® research and development; incorporates an E3 ligase ligand plus an alkylC1-PEG3-alkylC3 linker with terminal amine ready for conjugation to a target protein ligand | |||||
| GC50712 | VH 032 amide-alkylC2-acid | 2172819-72-4 | PROTAC | ||
Functionalized von-Hippel-Lindau protein ligand (VHL) for PROTAC® research and development; incorporates an E3 ligase ligand plus alkylC2 linker with terminal carboxylic acid ready for conjugation to a target protein ligand | |||||
| GC50723 | VH 101 phenol-alkylC4-amine | 2564467-03-2 | PROTAC | ||
Functionalized von-Hippel-Lindau protein ligand (VHL) for PROTAC® research and development; incorporates an E3 ligase ligand plus an alkylC4 linker with terminal amine ready for conjugation to a target protein ligand | |||||
| GC50724 | VH 032 amide-alkylC6-acid | 2172819-75-7 | PROTAC | ||
Functionalized von-Hippel-Lindau protein ligand (VHL) for PROTAC® research and development; incorporates an E3 ligase ligand plus alkylC6 linker with terminal carboxylic acid ready for conjugation to a target protein ligand | |||||
